Oxygenta Pharmaceutical Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-96.83	-34.79	-115.71	-6.1	29.3
Depreciation & Amortization	8.16	26.61	20.52	15.91	11.96
Provision & Write-off of Bad Debts	7.72	-	-	-	-
Other Operating Activities	-11.31	-87.45	16.81	9.2	17.6
Change in Accounts Receivable	11.8	31.96	-85.84	0.34	-11.87
Change in Inventory	-67.97	-20.11	-44.22	48.31	-78.61
Change in Accounts Payable	69.07	-39.57	212.07	-90.94	80.4
Change in Other Net Operating Assets	105.39	-7.13	-19.96	6.48	-65
Operating Cash Flow	26.03	-130.5	-16.34	-16.8	-16.22
Capital Expenditures	-113.92	-41.06	-96.45	-49.46	-67.41
Sale of Property, Plant & Equipment	1.2	-	-	-	-
Other Investing Activities	0.22	0.18	0.05	0.04	0.23
Investing Cash Flow	-112.49	-40.88	-96.4	-49.41	-67.19
Short-Term Debt Issued	324.78	-	-	-	-
Long-Term Debt Issued	-	-	127.12	32.57	104.5
Total Debt Issued	324.78	-	127.12	32.57	104.5
Long-Term Debt Repaid	-274.79	-107.6	-	-	-
Net Debt Issued (Repaid)	49.99	-107.6	127.12	32.57	104.5
Issuance of Common Stock	54.5	289.23	-	40	-
Other Financing Activities	-17.82	-10.32	-14.88	-9.25	-17.83
Financing Cash Flow	86.67	171.32	112.24	63.32	86.67
Miscellaneous Cash Flow Adjustments	0	-	-	0	-0
Net Cash Flow	0.21	-0.05	-0.5	-2.89	3.27
Free Cash Flow	-87.89	-171.55	-112.79	-66.26	-83.63
Free Cash Flow Margin	-8.04%	-43.28%	-36.40%	-10.95%	-16.07%
Free Cash Flow Per Share	-2.44	-5.35	-7.94	-5.20	-6.56
Cash Interest Paid	17.82	15.94	14.88	9.25	17.83
Cash Income Tax Paid	1.6	-	-	-	-
Levered Free Cash Flow	-54.68	-110.47	-95.62	-55.73	-146.96
Unlevered Free Cash Flow	-42.07	-100.59	-86.4	-50.01	-135.86
Change in Working Capital	118.29	-34.86	62.05	-35.81	-75.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.